MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,000 | -63.6% | 24 | -65.7% | 0.00% | -50.0% |
| Q2 2021 | $11,000 | -26.7% | 70 | -18.6% | 0.00% | -33.3% |
| Q1 2021 | $15,000 | -25.0% | 86 | -6.5% | 0.00% | -40.0% |
| Q4 2020 | $20,000 | -33.3% | 92 | -48.6% | 0.01% | -37.5% |
| Q3 2020 | $30,000 | -6.2% | 179 | -36.7% | 0.01% | -20.0% |
| Q2 2020 | $32,000 | +45.5% | 283 | 0.0% | 0.01% | +11.1% |
| Q1 2020 | $22,000 | -15.4% | 283 | +38.0% | 0.01% | +28.6% |
| Q4 2019 | $26,000 | +52.9% | 205 | -8.5% | 0.01% | -12.5% |
| Q3 2019 | $17,000 | -19.0% | 224 | +11.4% | 0.01% | -11.1% |
| Q2 2019 | $21,000 | – | 201 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |